ketoconazole has been researched along with flavin mononucleotide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KS; Atreya, C; Babatunde, O; Jorgensen, WL; Martucci, WE; Udier-Blagovic, M; Vargo, MA | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Burris-Hiday, SD; Scott, EE | 1 |
3 other study(ies) available for ketoconazole and flavin mononucleotide
| Article | Year |
|---|---|
Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen.
Topics: Allosteric Site; Animals; Catalytic Domain; Cryptosporidium; Enzyme Inhibitors; Folic Acid Antagonists; Models, Molecular; Tetrahydrofolate Dehydrogenase | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Allosteric modulation of cytochrome P450 enzymes by the NADPH cytochrome P450 reductase FMN-containing domain.
Topics: Cytochrome P-450 Enzyme System; Flavin Mononucleotide; Humans; Hydrogen Peroxide; Ketoconazole; Ligands; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Protein Domains; Recombinant Fusion Proteins; Steroid 21-Hydroxylase | 2023 |